Close Menu

Montreal Heart Institute

The two genome-wide scores to predict coronary artery disease risk, which were developed using UK Biobank data, were also valid in French-Canadians.

Although analyses for other drugs in the class have failed to confirm the influence of genotype, Dalcor is moving forward with its clinical trial, expecting some results by the end of this year.

The genetics center has launched an NGS panel for inherited cardiovascular diseases and plans to develop pharmacogenomics and cholesterol metabolism panels.

Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute will use Illumina technology to analyze their biobank samples.

The partners are using genomic data to improve understanding of cardiovascular disease and diabetes and identify markers linked to drug response.

The study found a strong association between the effects of dalcetrapib and a genetic variant in the gene ADCY9.

NEW YORK (GenomeWeb News) – The Montreal Heart Institute has partnered with several biotech companies and the Quebec government to launch a C$49.2 million (US$44.6 million) research program to that will use genetic and other biomarkers to develop personalized treatments for cardiovascular disease

By Monica Heger
This story was originally published Oct. 3.

Pages

The Washington Post reports that Herbert Tabor, who worked at the US National Institutes of Health for 77 years, has died at 101.

The World Bank is seeking approval for a $12 billion plan to provide low-income nations with funds to procure SARS-CoV-2 vaccines, according to Reuters.

Science writes that public health officials and others are debating whether cycle threshold values should be included on SARS-CoV-2 results.

In Nucleic Acids Research this week: online database of SARS-CoV-2 protein structures, atlas of the human brain, and more.